Table: begin end state 1 29 non-cytoplasmic 30 50 transmembrane 51 56 cytoplasmic 57 79 transmembrane 80 84 non-cytoplasmic 85 116 transmembrane 117 126 cytoplasmic 127 150 transmembrane 151 177 non-cytoplasmic 178 200 transmembrane 201 229 cytoplasmic 230 251 transmembrane 252 283 non-cytoplasmic 284 304 transmembrane 305 364 cytoplasmic 365 395 transmembrane 396 414 non-cytoplasmic 415 448 transmembrane 449 596 cytoplasmic
Input: >RR42_RS16025 FitnessBrowser__Cup4G11:RR42_RS16025 MRQPFPLAAFHPRLLDSLRDYNRALFFKDLAAGLTVGVVALPLAMAFAIASGMPPQAGLF TAIIAGFLIAALGGSPVQIGGPAGAFIVIVYGIVARYGVANLLIATILAGGLLFAMGLFR LGTLIRFIPVAIVIGFTNGIAVLIMVSQIADFLGLQTGKLPGNFLSQMRVLGRALPTVSW PTVALAVSSLVVVAGWSRLALLAGKRWRPVSTVAANPANPPNAHGRLGRALAMVPGTVIA LVLATAANGLLHLPVETIGTRFGGIPQGLPPFALPQLSWQLVQQLVAPTLTIALLGAIES LLCARVADSLIDDRHDPNQELMAQGIANIVTPFFGGLPATGTIARTVTNVRSGGRTPVAG MIHAATLLLIVLVAAPLASAIPLATLAAILLYVAWNMGEWHMFGLTHLKRYSNNYRIILL GTFVLTVVFDLTVAVQVGLVLACLFFIYRMAALTQIEAIAPAALPPAADGRPLPAGEVAA YHMTGALFFGAVNKVEALIDPRDRTQPVPAVLILDVGKLVALDTTGLDTLDALRKTLARR GGTLVICAAPAQVMSLMRRAGFLEQMGTANYCDTLAAACARAGVLLAERAERPAAG
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server